Kidney transplantation is the best possible treatment for many patients with end-stage renal
failure, but progressive dysfunction and eventual allograft loss with return to dialysis is …

Patients who receive a kidney transplant commonly experience failure of their allograft.
Transplant failure often comes with complex management decisions, such as when and how …

Belatacept, a costimulation blocker, may preserve renal function and improve long‐term
outcomes versus calcineurin inhibitors in kidney transplantation. This Phase III study …

The clinical profile of belatacept in kidney transplant recipients was evaluated to determine if
earlier results in the BENEFIT study were sustained at 3 years. BENEFIT is a randomized 3 …

The return to dialysis after allograft failure is associated with increased morbidity and
mortality. This transition is made more complex by the rising numbers of patients who seek …

Renal transplantation is a well established treatment for end-stage renal disease, allowing
most patients to return to a satisfactory quality of life. Studies have identified many problems …

The number of kidney transplant recipients returning to dialysis after graft failure is steadily
increasing over time. Patients with a failed kidney transplant have been shown to have a …

Background Infections and malignancies are the most common non-cardiovascular causes
of death in patients on chronic renal replacement therapy (RRT). Here, we aimed to quantify …

In March 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a virtual
Controversies Conference to address the important but rarely examined phase during which …

Background Although dialysis after kidney transplant failure (TF) is common, the outcomes
of these patients remain unclear. We compared outcomes of TF patients with transplant …